Can patients with schizophrenia take bupropion hydrochloride tablets?
Generally, patients with schizophrenia are not advised to take bupropion hydrochloride tablets. The detailed analysis is as follows:

Bupropion hydrochloride tablets are primarily used to treat depression and assist in smoking cessation. Their pharmacological action involves regulating neurotransmitters in the central nervous system, such as dopamine and norepinephrine. Such regulation may adversely affect patients with schizophrenia. The core pathological mechanism of schizophrenia involves imbalances in multiple neurotransmitters, particularly dysfunction in the dopamine system. The dopamine-enhancing effect of bupropion hydrochloride may exacerbate positive symptoms such as hallucinations and delusions in patients, potentially leading to mood fluctuations, restlessness, or even relapse of previously stabilized conditions, thus hindering symptom control and recovery.
In daily care for patients with schizophrenia, medications must be strictly selected according to medical advice; self-changing or adding drugs is strictly prohibited. It is important to provide the patient with a quiet and regular living environment, avoiding external stimuli that could trigger emotional fluctuations. Caregivers should also supervise the patient to take prescribed medications on time and in correct doses, while closely observing subtle changes in behavior and mood. If worsening symptoms or physical discomfort are noticed, prompt communication with the attending physician is necessary to adjust the treatment plan, ensuring both safety and effectiveness of therapy.